Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

1Q Earnings Preview: What To Expect From US, EU Big Hitters

Apr 26 2016

• By Scrip Team

Related Content

Merck, AZ, Roche, BMS work off grid for mix-and-match immuno-oncology

Jun 12 2015

Repatha OK'd; Payers Eye PCSK9 Rebate/Discount War

Aug 28 2015

Lantus Follow-On Basaglar OK'd, But Can Lilly Sell It?

Dec 17 2015

Sanofi Files LixiLan For Diabetes, Gambles Expensive Priority Review Voucher

Dec 23 2015

Sanofi paying big for FDA voucher; Retrophin snags $245m

May 28 2015

Lilly sets timelines for solanezumab

Apr 24 2015

Regeneron/Sanofi dermatitis drug dupilumab dubbed 'breakthrough'

Nov 21 2014

Lilly's Leap Tests Investors' Faith In Solanezumab

Mar 16 2016

Amgen's PCSK9 Patent Win: A Long-Term Value Shift?

Mar 17 2016

FDA OK's Lilly's Taltz; Rival To Novartis' Cosentyx

Mar 23 2016

Court Probes Rationale Of Biosimilars' 180-Day Notice

Apr 05 2016

'Transformative' Dupilumab Set For Third Quarter Filing In Atopic Dermatitis

Apr 01 2016

Amgen Mum On Repatha Sales; Outcomes Data Needed To Sway US Payers

Jan 29 2016

Related Companies

Eli Lilly and Company

Gilead Sciences, Inc.

Apotex Inc.

AstraZeneca PLC

Acerta Pharma BV

Pfizer Inc.

Sanofi

Regeneron Pharmaceuticals, Inc.

Boehringer Ingelheim GmbH

Novo Nordisk A/S

Takeda Pharmaceutical Co. Ltd.

Baxalta Incorporated

Bristol Myers Squibb Company

Merck & Co., Inc.

Ono Pharmaceutical Company, Ltd.

Additional Topics

Companies Business Strategies

More from Business

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window